A detailed history of M28 Capital Management LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, M28 Capital Management LP holds 110,400 shares of SWTX stock, worth $3.93 Million. This represents 3.36% of its overall portfolio holdings.

Number of Shares
110,400
Previous 110,400 -0.0%
Holding current value
$3.93 Million
Previous $4.16 Million 14.94%
% of portfolio
3.36%
Previous 4.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$36.5 - $52.5 $1.18 Million - $1.7 Million
-32,400 Reduced 22.69%
110,400 $5.43 Million
Q4 2023

Feb 12, 2024

SELL
$18.94 - $37.24 $1.04 Million - $2.04 Million
-54,900 Reduced 27.77%
142,800 $5.21 Million
Q1 2023

May 12, 2023

BUY
$24.97 - $34.05 $2.19 Million - $2.99 Million
87,800 Added 79.89%
197,700 $5.09 Million
Q4 2022

Feb 10, 2023

BUY
$21.73 - $28.72 $2.39 Million - $3.16 Million
109,900 New
109,900 $2.86 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.22B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track M28 Capital Management LP Portfolio

Follow M28 Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M28 Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on M28 Capital Management LP with notifications on news.